Are there certain clinical features that help you choose between benralizumab and mepolizumab for EGPA in clinical practice?

Does the severity of asthma play a role in decision making?

Answer from: at Community Practice

Not specifically. Both of these medications are effective in controlling severe asthma and allow for OCS reduction in EGPA patients, though benra did demonstrate more serum eosinophil depletion. The MANDARA trial demonstrated non-inferiority so both of these medications and MOAs are effective. Patie...

Comments

at Allergy And Asthma Consultants Of Rockland And Bergen
I would consider Mepolizumab 300 first if patient ...

Please select the option that best describes you:

Are there certain clinical features that help you choose between benralizumab and mepolizumab for EGPA in clinical practice?

Related Questions